A Comparison of Different Endovascular Treatment for Vertebral Artery Origin Stenosis

Zigao Wang1, Yifeng Ling1, Hongchen Zhao1

  • 1Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China.

World Neurosurgery
|June 14, 2022
PubMed

Insights

Drug-eluting stents (DES) are more effective than bare metal stents (BMS) for reducing restenosis in vertebral artery origin stenosis (VAOS). Angioplasty with drug-coated balloons (DCB) showed slower stenosis progression despite initial residual stenosis.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Vertebral artery origin stenosis (VAOS) can cause significant neurological symptoms.
  • Medical management alone is often insufficient for symptomatic VAOS.
  • Endovascular options are crucial for managing refractory VAOS.

Purpose of the Study:

  • To compare the safety and efficacy of drug-eluting stent (DES) versus bare metal stent (BMS) and angioplasty with drug-coated balloon (DCB) for symptomatic VAOS.
  • To evaluate outcomes including technical success, complications, residual stenosis, and long-term event rates.
  • To identify the optimal endovascular strategy for patients unresponsive to medical therapy.

Main Methods:

  • Retrospective analysis of 46 patients with symptomatic VAOS treated between December 2018 and November 2021.
  • Comparison of three treatment groups: DES (n=29), BMS (n=12), and DCB angioplasty (n=5).
  • Assessment of technical success, perioperative complications, residual stenosis, stroke recurrence, stenosis progression, and restenosis rates.

Main Results:

  • Technical success rates were 100% for DES, 100% for BMS, and 60% for DCB (P=0.008).
  • Restenosis rates were significantly lower with DES (6.9%) compared to BMS (50.0%) (P=0.007).
  • DCB group showed the slowest progression of residual stenosis (-8.0%) despite higher initial residual stenosis (51.2%).

Conclusions:

  • Drug-eluting stents (DES) demonstrate superior efficacy in reducing restenosis rates compared to bare metal stents (BMS) in VAOS.
  • Angioplasty with drug-coated balloons (DCB) offers a viable alternative, characterized by slower stenosis progression.
  • Endovascular treatment strategies should be individualized based on patient factors and desired outcomes for symptomatic VAOS.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
29
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29